FOXO TECHNOLOGIES INC. Marketable Securities, Unrealized Gain (Loss)
FOXO TECHNOLOGIES INC. (FOXO) reported Marketable Securities, Unrealized Gain (Loss) of -$5.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2022-08-12
- FOXO TECHNOLOGIES INC. marketable securities, unrealized gain (loss) for the quarter ending 2022-06-30 was -$5.00K.
- FOXO TECHNOLOGIES INC. marketable securities, unrealized gain (loss) for the quarter ending 2022-03-31 was $5.00K, a 376.38% increase year-over-year.
- FOXO TECHNOLOGIES INC. marketable securities, unrealized gain (loss) for the quarter ending 2021-12-31 was $1.05K.
- FOXO TECHNOLOGIES INC. marketable securities, unrealized gain (loss) for the quarter ending 2021-09-30 was $0.00.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 8 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | -$5.00K 10-Q · filed 2022-08-12 | $0.00 derived: sum of 2 quarters · filed 2022-08-12 | $1.05K derived: sum of 3 quarters · filed 2022-08-12 | $1.05K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2022-03-31 | $5.00K 10-Q · filed 2022-05-16 | $6.05K derived: sum of 2 quarters · filed 2022-05-16 | $6.05K derived: sum of 3 quarters · filed 2022-05-16 | $6.05K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-12-31 | $1.05K 10-K · filed 2022-03-07 | $1.05K derived: sum of 2 quarters · filed 2022-03-07 | $1.05K derived: sum of 3 quarters · filed 2022-08-12 | $2.10K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2022-08-12 | $1.05K 10-Q · filed 2021-11-15 | $0.00 derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.05K 10-Q · filed 2022-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $1.05K 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | |||
| 2020-12-31 | -$1.05K 10-K · filed 2022-03-07 | -$1.05K 10-K/A · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |